Results 111 to 120 of about 7,143 (200)

A cross-sectional observational study: assessment of cardiovascular damage in mucopolysaccharidoses mutation carriers. [PDF]

Cardiovasc Diagn Ther
Nguyen TL, Semyachkina AN, Voinova VY, Shkolnikova MA, Luong TA, Le HK, Reznik EV.   +6 more
europepmc   +1 more source

AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidoses. [PDF]

J Manag Care Spec Pharm
Flavin B, Haumschild R, Klein TK, McKay K, Mok T, O'Neill C, Rice M, Stephens K, Stoltz E.   +8 more
europepmc   +1 more source

MUSCULOSKELETAL ALTERATIONS OF ORTHOPEDIC INTEREST IN MUCOPOLYSACCHARIDOSES. [PDF]

Acta Ortop Bras
Matos MA, Lopes PS.
europepmc   +1 more source

Guidance for Home Enzyme Replacement Therapy in Children and Adolescents Diagnosed with Mucopolysaccharidoses: A Scoping Review Protocol. [PDF]

Int J Environ Res Public Health
Oliveira VR, Martins YNF, Araújo JIF, Silva EFD, Fuentes MB, Oliveira JSA.   +5 more
europepmc   +1 more source

Orofacial manifestations in mucopolysaccharidoses: a comprehensive clinical and radiographic evaluation of 35 pediatric cases. [PDF]

Head Face Med
Çoğulu D, Uçar SK, Canda E, Atila EK, Alpöz AR, Çoker M.   +5 more
europepmc   +1 more source

Commentary: Lysosomal enzymes engineered to cross the blood-brain barrier are reshaping the therapeutic landscape of neuronopathic mucopolysaccharidoses. [PDF]

Neurotherapeutics
Sorrentino NC, Fraldi A.
europepmc   +1 more source

Mucopolysaccharidoses: A biochemical study under limited resources. [PDF]

Mol Genet Metab Rep
Bouzid F, El Fissi H, Karim K, Sebbar MS, Jabir B, Chuis N, Msanda F, Alif N.   +7 more
europepmc   +1 more source

Retinal microstructual and microvascular changes in mucopolysaccharidoses. [PDF]

Graefes Arch Clin Exp Ophthalmol
Wipprecht L, Borchers AJ, Stingl JV, Schmitz LS, von Plettenberg K, Hennermann JB, Hopf S, Pitz S, Matlach J.   +8 more
europepmc   +1 more source

Advances in mucopolysaccharidosis research: the impact of mass spectrometry-based approaches. [PDF]

Clin Proteomics
Ramarajan MG, Garapati K, Ghose V, Pandey A.   +3 more
europepmc   +1 more source

Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases. [PDF]

Orphanet J Rare Dis
Douillard C, Poujois A, Belmatoug N, Lidove O, Leguy-Seguin V, Mauhin W, Gorce M, Cano A, Labrune P, Mazodier K, Wicker C, Maillot F, Brassier A, Guemann AS, Habes D, Abi-Warde MT, Redonnet-Vernhet I, Germain DP, Lavigne C, Khemiri A, Mention K, Dao M, Héron B, Berger MG, Lonlay P.   +24 more
europepmc   +1 more source